343 related articles for article (PubMed ID: 11356980)
1. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment.
Penin F; Combet C; Germanidis G; Frainais PO; Deléage G; Pawlotsky JM
J Virol; 2001 Jun; 75(12):5703-10. PubMed ID: 11356980
[TBL] [Abstract][Full Text] [Related]
2. Evolutionary study of hepatitis C virus envelope genes during primary infection.
Chen S; Wang YM
Chin Med J (Engl); 2007 Dec; 120(24):2174-80. PubMed ID: 18167197
[TBL] [Abstract][Full Text] [Related]
3. Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry.
Callens N; Ciczora Y; Bartosch B; Vu-Dac N; Cosset FL; Pawlotsky JM; Penin F; Dubuisson J
J Virol; 2005 Dec; 79(24):15331-41. PubMed ID: 16306604
[TBL] [Abstract][Full Text] [Related]
4. Evolution of hepatitis C virus hypervariable region 1 in immunocompetent children born to HCV-infected mothers.
Gismondi MI; Becker PD; Díaz Carrasco JM; Guzmán CA; Campos RH; Preciado MV
J Viral Hepat; 2009 May; 16(5):332-9. PubMed ID: 19228286
[TBL] [Abstract][Full Text] [Related]
5. E2 quasispecies specificity of hepatitis C virus association with allografts immediately after liver transplantation.
Hughes MG; Rudy CK; Chong TW; Smith RL; Evans HL; Iezzoni JC; Sawyer RG; Pruett TL
Liver Transpl; 2004 Feb; 10(2):208-16. PubMed ID: 14762858
[TBL] [Abstract][Full Text] [Related]
6. Variations in the hypervariable region 1 of the envelope region E2 of hepatitis C virus RNA appear associated with virus persistence independently of liver disease.
Brunetto MR; Suzuki T; Aizaky H; Flichman D; Colombatto P; Abate ML; Oliveri F; Matsuura Y; Bonino F; Miyamura T
Ital J Gastroenterol; 1996 Dec; 28(9):499-504. PubMed ID: 9131394
[TBL] [Abstract][Full Text] [Related]
7. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.
Zibert A; Schreier E; Roggendorf M
Virology; 1995 Apr; 208(2):653-61. PubMed ID: 7538251
[TBL] [Abstract][Full Text] [Related]
8. Characterization of hypervariable region in hepatitis C virus envelope protein during acute and chronic infection.
Higashi K; Tsukiyama-Kohara K; Tanaka T; Tanaka E; Kiyosawa K; Kohara M
Arch Virol; 2005 May; 150(5):883-98. PubMed ID: 15662481
[TBL] [Abstract][Full Text] [Related]
9. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
[TBL] [Abstract][Full Text] [Related]
10. Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation.
Mondelli MU; Cerino A; Lisa A; Brambilla S; Segagni L; Cividini A; Bissolati M; Missale G; Bellati G; Meola A; Bruniercole B; Nicosia A; Galfrè G; Silini E
Hepatology; 1999 Aug; 30(2):537-45. PubMed ID: 10421665
[TBL] [Abstract][Full Text] [Related]
11. [Sequence diversity of genotype II/1b hepatitis C virus (HCV) HVR1 of 46 patients in Beijing areas].
Zhao J; Cheng Y; Zhang H
Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):88-90. PubMed ID: 10488415
[TBL] [Abstract][Full Text] [Related]
12. Sequences in the hypervariable region 1 of hepatitis C virus show only minimal variability in the presence of antibodies against hypervariable region 1 during acute infection in chimpanzees.
Zhou YH; Sugitani M; Esumi M
Arch Virol; 2002 Oct; 147(10):1955-62. PubMed ID: 12376756
[TBL] [Abstract][Full Text] [Related]
13. Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants.
Puntoriero G; Meola A; Lahm A; Zucchelli S; Ercole BB; Tafi R; Pezzanera M; Mondelli MU; Cortese R; Tramontano A; Galfre' G; Nicosia A
EMBO J; 1998 Jul; 17(13):3521-33. PubMed ID: 9649423
[TBL] [Abstract][Full Text] [Related]
14. Mimotopes of the hepatitis C virus hypervariable region 1, but not the natural sequences, induce cross-reactive antibody response by genetic immunization.
Zucchelli S; Roccasecca R; Meola A; Ercole BB; Tafi R; Dubuisson J; Galfré G; Cortese R; Nicosia A
Hepatology; 2001 Mar; 33(3):692-703. PubMed ID: 11230750
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of hypervariable region 1-specific and -cross-reactive CD4(+) T cells in HCV-infected individuals responsive to IFN-alpha treatment.
Del Porto P; Puntoriero G; Scottà C; Nicosia A; Piccolella E
Virology; 2000 Apr; 269(2):313-24. PubMed ID: 10753710
[TBL] [Abstract][Full Text] [Related]
16. The hypervariable region 1 protein of hepatitis C virus broadly reactive with sera of patients with chronic hepatitis C has a similar amino acid sequence with the consensus sequence.
Watanabe K; Yoshioka K; Ito H; Ishigami M; Takagi K; Utsunomiya S; Kobayashi M; Kishimoto H; Yano M; Kakumu S
Virology; 1999 Nov; 264(1):153-8. PubMed ID: 10544140
[TBL] [Abstract][Full Text] [Related]
17. Differential amplification of hypervariable region 1 of hepatitis C virus by partially mismatched primers.
Fan X; Lyra AC; Tan D; Xu Y; Di Bisceglie AM
Biochem Biophys Res Commun; 2001 Jun; 284(3):694-7. PubMed ID: 11396957
[TBL] [Abstract][Full Text] [Related]
18. Genetic complexity and serum reactivity of HVR1 quasispecies of hepatitis C virus in patients with cirrhosis.
Fan X; Di Bisceglie AM
Am J Gastroenterol; 2002 Jun; 97(6):1489-95. PubMed ID: 12094871
[TBL] [Abstract][Full Text] [Related]
19. Broadly reactive antibodies to hypervariable region 1 in hepatitis C virus-infected patient sera: relation to viral loads and response to interferon.
Hattori M; Yoshioka K; Aiyama T; Iwata K; Terazawa Y; Ishigami M; Yano M; Kakumu S
Hepatology; 1998 Jun; 27(6):1703-10. PubMed ID: 9620346
[TBL] [Abstract][Full Text] [Related]
20. T cell recognition of hypervariable region-1 from hepatitis C virus envelope protein with multiple class II MHC molecules in mice and humans: preferential help for induction of antibodies to the hypervariable region.
Shirai M; Arichi T; Chen M; Masaki T; Nishioka M; Ikeda K; Takahashi H; Enomoto N; Saito T; Major ME; Nakazawa T; Akatsuka T; Feinstone SM; Berzofsky JA
J Immunol; 1999 Jan; 162(1):568-76. PubMed ID: 9886434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
